Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Embion

Explore full profile

Procurement automation to non-hospital-based providers

Minneapolis, United StatesFounded 1998Biotech & Life Sciences
Valuation $50–100M Last recorded · 2000
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Embion and the history behind them.

About Embion

Embion Technologies SA, a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL), was founded in 2016 by three chemical engineering scientists: Georgios Savoglidis, Sviatlana Siankevich, and Georgios Fengos. The founders met while studying at the University of Patras in Greece and shared a vision for a new approach to the bioeconomy. Savoglidis, the CEO, brings over 15 years of experience in biotech and chemical engineering, complemented by business experience in his family's SME. Siankevich, the CTO, has a background in environmental science and extensive postdoctoral experience at EPFL developing catalytic systems for sustainable chemical production from biomass.

The company operates in the industrial biotechnology and green chemistry sectors, focusing on upcycling industrial biomass side-streams into high-value products for nutrition and health. Its core is a proprietary and patented platform technology that uses a novel ionic catalyst approach for the efficient extraction and formulation of bioactive compounds. This technology significantly accelerates the development-to-production timeline, reducing a typical five-year process to just one year. Embion's business model centers on collaborating with industry leaders in sectors like food, feed, cosmetics, and materials to develop and commercialize these solutions. Revenue is generated through the sale of its high-performance plant-based bioactives.

Embion's flagship product is PREMBION®, a patented, GMO-free prebiotic derived from brewers' spent grains. This soluble powder is designed to improve animal health by modulating the gut microbiome, selectively promoting beneficial microbes, and offering an alternative to antibiotics in farming. The technology platform itself is a key offering, enabling partners to innovate responsibly by transforming their by-products into valuable ingredients for human nutrition, personal care, and animal feed. Since its founding, Embion has secured multiple rounds of funding, including a Series A round of CHF 4.5 million in 2021 led by Asahi Group Holdings. The company was also recognized as a Technology Pioneer by the World Economic Forum.

Source: Dealroom company data

At a glance

Status
Closed
Founded
1998
Headquarters
Minneapolis, United States
Open positions
None listed
Dealroom signal
0.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Nutrition, Microbiome, Techbio, Hard Tech, DT and LS, science-based
Client focus
b2b
Links
Website

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Jan 2000 $10M $40M Acacia Venture Partners · U.S. Bank —
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Acacia Venture Partners
  • U.S. Bank
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Minneapolis HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Embion on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Embion’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.